A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. (Q46034285)
Jump to navigation
Jump to search
scientific article published in July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. |
scientific article published in July 2009 |
Statements
1 reference
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. (English)
1 reference
1 reference
1 reference
1 reference
Daniel Podzamczer
1 reference
Bonaventura Clotet
1 reference
Josep M Llibre
1 reference
David Dalmau
1 reference
Josep Mallolas
1 reference
Montserrat Loncá
1 reference
José M Gatell
1 reference
Judit Pich
1 reference
Pilar Barrufet
1 reference
Patricia Barragán
1 reference
Hernando Knobel
1 reference
Esteban MartÃnez
1 reference
José A Arranz
1 reference
José Sanz
1 reference
Victor Roca
1 reference
Félix Gutiérrez
1 reference
José L Blanco
1 reference
Ferran Segura
1 reference
Jaime CosÃn
1 reference
Esperanza Casas
1 reference
Elena Ferrer
1 reference
Alicia González
1 reference
Ana Cruceta
1 reference
Joan A Arnaiz
1 reference
José M Miró
1 reference
BICOMBO Study Team
1 reference
1 July 2009
1 reference
51
1 reference
290-297
1 reference
3
1 reference
Identifiers
1 reference
1 reference